Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$9.6 million.

  • Profound Medical's Cash from Operations fell 4084.38% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.5 million, marking a year-over-year decrease of 5066.46%. This contributed to the annual value of -$23.5 million for FY2024, which is 373.3% down from last year.
  • As of Q3 2025, Profound Medical's Cash from Operations stood at -$9.6 million, which was down 4084.38% from -$13.7 million recorded in Q2 2025.
  • Over the past 5 years, Profound Medical's Cash from Operations peaked at $5.8 million during Q1 2023, and registered a low of -$26.2 million during Q3 2023.
  • Its 3-year average for Cash from Operations is -$7.1 million, with a median of -$6.8 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Profound Medical's Cash from Operations was 7396.84% (2024), while the steepest drop was 22148.86% (2024).
  • Profound Medical's Cash from Operations (Quarter) stood at -$7.3 million in 2023, then rose by 19.78% to -$5.9 million in 2024, then crashed by 63.53% to -$9.6 million in 2025.
  • Its last three reported values are -$9.6 million in Q3 2025, -$13.7 million for Q2 2025, and -$8.3 million during Q1 2025.